Cargando…
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386339/ https://www.ncbi.nlm.nih.gov/pubmed/28157216 http://dx.doi.org/10.1038/bcj.2017.5 |
_version_ | 1782520749864517632 |
---|---|
author | Montillo, M O'Brien, S Tedeschi, A Byrd, J C Dearden, C Gill, D Brown, J R Barrientos, J C Mulligan, S P Furman, R R Cymbalista, F Plascencia, C Chang, S Hsu, E James, D F Hillmen, P |
author_facet | Montillo, M O'Brien, S Tedeschi, A Byrd, J C Dearden, C Gill, D Brown, J R Barrientos, J C Mulligan, S P Furman, R R Cymbalista, F Plascencia, C Chang, S Hsu, E James, D F Hillmen, P |
author_sort | Montillo, M |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5386339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-53863392017-04-26 Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study Montillo, M O'Brien, S Tedeschi, A Byrd, J C Dearden, C Gill, D Brown, J R Barrientos, J C Mulligan, S P Furman, R R Cymbalista, F Plascencia, C Chang, S Hsu, E James, D F Hillmen, P Blood Cancer J Letter to the Editor Nature Publishing Group 2017-02 2017-02-03 /pmc/articles/PMC5386339/ /pubmed/28157216 http://dx.doi.org/10.1038/bcj.2017.5 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Letter to the Editor Montillo, M O'Brien, S Tedeschi, A Byrd, J C Dearden, C Gill, D Brown, J R Barrientos, J C Mulligan, S P Furman, R R Cymbalista, F Plascencia, C Chang, S Hsu, E James, D F Hillmen, P Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study |
title | Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study |
title_full | Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study |
title_fullStr | Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study |
title_full_unstemmed | Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study |
title_short | Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study |
title_sort | ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the resonate study |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386339/ https://www.ncbi.nlm.nih.gov/pubmed/28157216 http://dx.doi.org/10.1038/bcj.2017.5 |
work_keys_str_mv | AT montillom ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT obriens ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT tedeschia ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT byrdjc ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT deardenc ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT gilld ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT brownjr ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT barrientosjc ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT mulligansp ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT furmanrr ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT cymbalistaf ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT plascenciac ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT changs ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT hsue ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT jamesdf ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy AT hillmenp ibrutinibinpreviouslytreatedchroniclymphocyticleukemiapatientswithautoimmunecytopeniasintheresonatestudy |